Thursday, May 7, 2026

TWILIGHT OF THE ARCHIPELAGO : Why The New Missiles In Kumamoto Are Triggering A Strategic Storm

North Korea warns Japan's missile deployment could lead to catastrophe, criticizing its aggressive military strategy and questioning its motives.

Hugel Hosts Medical Aesthetics Exchange… Expanding Reach of K-Aesthetics

Hugel Inc. hosted a Medical Aesthetics International Exchange, sharing trends and techniques among Asian medical professionals.

Ex-President Yoon Implicated in Explosive Treason Case Over North Korea Drone Flights

Commander Kim Yong Dae is questioned over alleged treason related to UAV operations amid the 2024 South Korean Martial Law Crisis.

Health

CG Bio Group Launches Acellular Dermal Matrix-based Product Reallo Inject Fine

CG Bio launches Reallo Inject Fine, an acellular dermal matrix product, enhancing usability for medical professionals and expanding applications.

Ceragem Launches Global Standard for AI Home Healthcare, Accelerates Data Platform Push

Ceragem's new ISO/IEC report sets international standards for integrating home healthcare devices, focusing on user well-being and safety.

Hugel Participates AMWC ASIA & TDAC 2026 at the Taipei International Convention Center, Taiwan

Hugel targets Taiwan's aesthetic market, showcasing products at AMWC ASIA & TDAC 2026, while expanding in Indonesia with educational programs.

L&K BioMed Showcases Innovative Products at the AANS Conference in Texas

L&K BioMed showcased its products at the AANS conference, receiving positive feedback and interest for its cervical products, aiming to expand in the U.S. market.

Seers Signs $14.7 Million Contract with UAE to Supply 105,000 Units over 3 Years

Seers signs a major deal for mobiCARE devices in the UAE, aiming for 50% growth and expansion into Vietnam and beyond.
Latest

How MiniRin and Nokdernah Are Revolutionizing Nocturia Care for Seniors: A Comprehensive Guide

Hanmi Pharmaceutical and Ferring Korea partner to distribute Minirin and Nocdurna for nocturia treatment, enhancing patient access.

Celltrion’s Eydenzelt: How Strategic Patent Agreements Enable U.S. and European Market Entry in 2026

Celltrion's Eydenzelt secures global distribution via strategic patent agreements, aiming for swift market entry in the U.S. and Europe.

Is RPG-102 the Future of Obesity Treatment? Discover the Breakthrough Oral Solution!

ProGen and Rani Therapeutics initiate a Phase 1 trial for RPG-102, an oral obesity treatment, aiming for effective weight loss with weekly dosing.

How CLOSER AI is Revolutionizing Depression Diagnosis: Insights from KAIST’s Latest Research

KAIST's AI tool CLOSER detects depression symptoms through daily behavior analysis, paving the way for personalized treatment options.

Revolutionizing Mental Health: How AI-Powered Legion Health is Redefining Patient Care

ZD Ventures invests in Legion Health, a telemedicine clinic, leveraging AI to improve mental health care efficiency in the U.S.

HK inno.N’s New Drug K-CAB Applies for U.S. FDA Approval: How Innovative Is the P-CAB Therapy?

HK inno.N's K-Cap for GERD has entered the U.S. approval process, showing superior results in clinical trials over existing treatments.

How Neurophet AQUA is Transforming Dementia Diagnosis in South Korea: Key MOU Insights

Neurophet partners with Eisai Korea to enhance dementia screening and diagnostics using AI-based software, Neurophet AQUA.

Revolutionizing Kidney Stone Surgery: Roen Surgical’s AI Robot Zamenix Launches in Indonesia

Roen Surgical exports AI-powered kidney stone surgery robot Zamenix to Indonesia, enhancing surgical precision and safety in healthcare.

CES 2026: Medicube’s Beauty Tech Innovations Captivate 1,600 Visitors – What You Need to Know

APR Co Ltd successfully showcased its Medicube beauty tech at CES 2026, attracting 1,600 visitors and planning global expansion.

HLB’s Liragratinib: A Game-Changer in Cholangiocarcinoma Treatment Revealed at ASCO GI 2026!

HLB's lirafugratinib shows promise as a precision oncology drug, targeting FGFR2 in cancer treatment. FDA application expected soon.

SK Biofarm, FDA Approved Radioactive Method: Will it be a Revolutionary Cancer Cure with SLK 33501?

SK Biopharmaceuticals gains FDA approval for Phase 1 trials of radiopharmaceuticals SKL35501 and SKL35502, advancing cancer treatment.

The Easiest Way To Lose Investor Trust? Just Steal $6.7 Billion! BMS Masterclass In Bad Business

Bristol Myers Squibb faces a $6.7B lawsuit over alleged delays in drug approvals affecting former Celgene shareholders' payouts.

Global Pharma Giants Join Samsung Biologics in Major Climate Pledge to Cut Supply-Chain Emissions by 2030

Samsung Biologics leads a global initiative to reduce carbon emissions in healthcare, aiming for sustainability and renewable energy by 2030.

TRUST ME, I’m an Expert: Trump’s Tylenol-Autism Claim Exposes Washington’s Dangerous NEW Brand of Idiocy

Trump claims Tylenol during pregnancy may raise autism risk, but medical experts refute this as unsupported by scientific evidence.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.